The forecast for the sold production of medicaments containing penicillins or other antibiotics in Germany indicates a steady growth from 2024 to 2028, starting at 2.7885 billion Euros in 2024 and reaching 2.8345 billion Euros by 2028. The year-on-year growth rate is consistently positive, highlighting a stable upward trend in this sector.
Looking at the broader picture, the expected compound annual growth rate (CAGR) from 2024 to 2028 reflects moderate but steady progression, suggesting sustained demand or strategic advancements in production capabilities.
Key trends to monitor include advancements in antibiotic alternatives, changes in healthcare policies affecting antibiotic usage, potential supply chain disruptions, and increased emphasis on antibiotic resistance management. These factors could significantly impact the demand and production of antibiotics in the coming years.
